Ultracet

DRUG5 trials

Sponsors

Chung Shan Medical University, Par Pharmaceutical, Inc., Merck Sharp & Dohme LLC, Charleston Laboratories, Inc

Conditions

Ankylosing SpondylitisHealthyOsteoarthritisTo Determine Bioequivalence Under Fasting ConditionsTo Determine Bioequivalence Under Fed Conditions

Phase 1

Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions

CompletedNCT00652821

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fed Conditions

Start: 2002-05-31End: 2002-08-31Updated: 2017-09-26

Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions

CompletedNCT00653315

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fasting Conditions

Start: 2002-05-31End: 2002-08-31Updated: 2008-04-11

A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)

CompletedNCT00772967

Merck Sharp & Dohme LLCOsteoarthritis

Start: 2008-06-30End: 2008-11-30Updated: 2015-11-20

A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

CompletedNCT02465866

Charleston Laboratories, IncHealthy

Start: 2014-11-30End: 2015-04-30Updated: 2017-05-02

Phase 4

Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis

CompletedNCT00647517

Chung Shan Medical UniversityAnkylosing Spondylitis

Start: 2008-03-31End: 2009-07-31Updated: 2010-04-01

Related Papers

A walking model to assess the onset of analgesia in osteoarthritis knee pain.

2010-02-0610 citations